Literature DB >> 25526708

TARDBP pathogenic mutations increase cytoplasmic translocation of TDP-43 and cause reduction of endoplasmic reticulum Ca²⁺ signaling in motor neurons.

R Mutihac1, J Alegre-Abarrategui2, D Gordon3, L Farrimond4, M Yamasaki-Mann5, K Talbot6, R Wade-Martins7.   

Abstract

The transactive response DNA binding protein (TDP-43) is a major component of the characteristic neuronal cytoplasmic inclusions seen in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Furthermore, pathogenic mutations in the gene encoding TDP-43, TARDBP, are found in sporadic and familial ALS cases. To study the molecular mechanisms of cellular toxicity due to TDP-43 mutations we generated a novel in vitro cellular model using a fluorescently tagged human genomic TARDBP locus carrying one of two ALS-associated mutations, A382T or M337V, which were used to generate site-specific bacterial artificial chromosome (BAC) human stable cell lines and BAC transgenic mice. In cell lines and primary motor neurons in culture, TDP-M337V mislocalized to the cytoplasm more frequently than wild-type TDP (wt-TDP) and TDP-A382T, an effect potentiated by oxidative stress. Expression of mutant TDP-M337V correlated with increased apoptosis detected by cleaved caspase-3 staining. Cells expressing mislocalized TDP-M337V spontaneously developed cytoplasmic aggregates, while for TDP-A382T aggregates were only revealed after endoplasmic reticulum (ER) stress induced by the calcium-modifying drug thapsigargin. Lowering Ca(2+) concentration in the ER of wt-TDP cells partially recapitulated the effect of pathogenic mutations by increasing TDP-43 cytoplasmic mislocalization, suggesting Ca(2+) dysregulation as a potential mediator of pathology through alterations in Bcl-2 protein levels. Ca(2+) signaling from the ER was impaired in immortalized cells and primary neurons carrying TDP-43 mutations, with a 50% reduction in the levels of luminal ER Ca(2+) stores content and delayed Ca(2+) release compared with cells carrying wt-TDP. The deficits in Ca(2+) release in human cells correlated with the upregulation of Bcl-2 and siRNA-mediated knockdown of Bcl-2 restored the amplitude of Ca(2+) oscillations in TDP-M337V cells. These results suggest that TDP-43 pathogenic mutations elicit cytoplasmic mislocalization of TDP-43 and Bcl-2 mediated ER Ca(2+) signaling dysregulation.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Bcl-2; Ca(2+) dysregulation; Motor neurons; TDP-43

Mesh:

Substances:

Year:  2014        PMID: 25526708     DOI: 10.1016/j.nbd.2014.12.010

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  23 in total

Review 1.  Mechanisms of TDP-43 Proteinopathy Onset and Propagation.

Authors:  Han-Jou Chen; Jacqueline C Mitchell
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

2.  Targeting phosphoglycerate kinase 1 with terazosin improves motor neuron phenotypes in multiple models of amyotrophic lateral sclerosis.

Authors:  Helena Chaytow; Emily Carroll; David Gordon; Yu-Ting Huang; Dinja van der Hoorn; Hannah Louise Smith; Thomas Becker; Catherina Gwynne Becker; Kiterie Maud Edwige Faller; Kevin Talbot; Thomas Henry Gillingwater
Journal:  EBioMedicine       Date:  2022-08-11       Impact factor: 11.205

Review 3.  TDP43 and RNA instability in amyotrophic lateral sclerosis.

Authors:  Kaitlin Weskamp; Sami J Barmada
Journal:  Brain Res       Date:  2018-01-31       Impact factor: 3.252

Review 4.  Frontotemporal Lobar Degeneration: Mechanisms and Therapeutic Strategies.

Authors:  Ya-Qing Li; Meng-Shan Tan; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2015-11-04       Impact factor: 5.590

Review 5.  Frontotemporal dementia: latest evidence and clinical implications.

Authors:  Juan Joseph Young; Mallika Lavakumar; Deena Tampi; Silpa Balachandran; Rajesh R Tampi
Journal:  Ther Adv Psychopharmacol       Date:  2017-11-10

Review 6.  Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.

Authors:  Alistair Wood; Yuval Gurfinkel; Nicole Polain; Wesley Lamont; Sarah Lyn Rea
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

7.  Valproate Attenuates 25-kDa C-Terminal Fragment of TDP-43-Induced Neuronal Toxicity via Suppressing Endoplasmic Reticulum Stress and Activating Autophagy.

Authors:  Xuejing Wang; Mingming Ma; Junfang Teng; Xiangqian Che; Wenwen Zhang; Shuman Feng; Shuang Zhou; Ying Zhang; Erxi Wu; Xuebing Ding
Journal:  Int J Biol Sci       Date:  2015-05-19       Impact factor: 6.580

8.  Rapid in vitro quantification of TDP-43 and FUS mislocalisation for screening of gene variants implicated in frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Lisa J Oyston; Stephanie Ubiparipovic; Lauren Fitzpatrick; Marianne Hallupp; Lauren M Boccanfuso; John B Kwok; Carol Dobson-Stone
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

9.  C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.

Authors:  Ruxandra Dafinca; Jakub Scaber; Nida'a Ababneh; Tatjana Lalic; Gregory Weir; Helen Christian; Jane Vowles; Andrew G L Douglas; Alexandra Fletcher-Jones; Cathy Browne; Mahito Nakanishi; Martin R Turner; Richard Wade-Martins; Sally A Cowley; Kevin Talbot
Journal:  Stem Cells       Date:  2016-05-04       Impact factor: 6.277

10.  Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels.

Authors:  Annekathrin Moller; Claudia S Bauer; Rebecca N Cohen; Christopher P Webster; Kurt J De Vos
Journal:  Hum Mol Genet       Date:  2017-12-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.